GlassScriptPhysician profile
Howard A Grossman
NPI 1710951694
$131,287.73
in general payments reported to CMS, 2019-2025
20 companies · $2,215 in 2025
The $2,215 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $28K · 2021: $25K · 2022: $38K · 2023: $5,580 · 2024: $979 · 2025: $2,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,270 · Food and Beverage: $2,540 · Consulting Fee: $1,140 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,270.00 |
| Food and Beverage | $2,539.76 |
| Consulting Fee | $1,140.00 |
| Travel and Lodging | $824.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $69,211.84 | 2019-2025 | Descovy, Biktarvy, Epclusa |
| Viiv Healthcare Company | $58,848.57 | 2019-2025 | Cabenuva, Apretude, Dovato |
| Theratechnologies INC. | $1,579.26 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $416.52 | 2019-2025 | Pifeltro, Capvaxive, Gardasil 9 |
| Janssen Biotech, INC. | $350.01 | 2019-2022 | |
| Janssen Products, LP | $251.45 | 2019-2021 | |
| Napo Pharmaceuticals INC | $228.49 | 2019-2025 | Mytesi |
| Janssen Scientific Affairs, LLC | $78.53 | 2019-2022 | |
| Emd Serono, INC. | $69.76 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.36 | 2022 | |
| Paratek Pharmaceuticals, INC. | $31.27 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $29.44 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.72 | 2022 | |
| Abbvie INC. | $23.59 | 2023 | |
| Exact Sciences Corporation | $20.67 | 2025 | Cologuard Collection Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.40 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Lilly USA, LLC | $18.13 | 2022 | |
| Allergan, INC. | $17.61 | 2020 | |
| Mylan Institutional INC. | $13.83 | 2019 | |
| Dynavax Technologies Corporation | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.